drugset / Trial / NCT06564207
Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults
Phase 2
Not yet recruiting
40 enrolled
Inova Health Care Services
Biomedical Advanced Research and Development Authority · collabRigel Pharmaceuticals · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to evaluate the safety and efficacy of fostamatinib in hospitalized adult participants with acute respiratory distress syndrome (ARDS).
Timeline
- Start
- 2026-08-30
- Primary completion
- 2027-05-31
- Completion
- 2027-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fostamatinib | Small molecule | 150 mg | — |